Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Justin Renz
Justin Renz is recorded as CFO at Zevra Therapeutics, Inc. (ZVRA) and Chief Accounting Officer at Ardelyx, Inc. (ARDX). Zevra Therapeutics, Inc. reported in an 8-K filed March 9, 2026 that Justin Renz was appointed principal financial officer, effective March 10, 2026. Zevra Therapeutics, Inc. reported in an 8-K filed March 9, 2026 that Justin Renz was appointed Chief Financial Officer and Treasurer, effective March 9, 2026. The proxy statement of Ardelyx, Inc. reports total compensation of $3,551,684 for Justin Renz in fiscal 2025, including a base salary of $464,434. Disclosed compensation is on record for 4 fiscal years. Justin Renz has spoken on 19 earnings calls and 2 other investor events across 2 companies, most recently for Zevra Therapeutics, Inc. on September 14, 2026.
“On March 4, 2026, the Company appointed Justin Renz as Chief Financial Officer and Treasurer, effective March 9, 2026, and as principal financial officer, effective March 10, 2026.”
Zevra Therapeutics, Inc. Form 8-K, filed March 9, 2026
· Read the filing
“On March 4, 2026, the Company appointed Justin Renz as Chief Financial Officer and Treasurer, effective March 9, 2026, and as principal financial officer, effective March 10, 2026.”
Zevra Therapeutics, Inc. Form 8-K, filed March 9, 2026
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
